Bio-waiver for Pregabalin Capsules [Dissolution / BCS / IVIVC]

posted by Anand – India, 2015-03-11 12:38 (3331 d 17:11 ago) – Posting: # 14559
Views: 13,629

Dear All,

We are developing Pregabalin Capsules,

We are going to file BCS based Bio-waiver approach by below data,

Drug Solubility:
  1. API Solubility(pH 1.2 to 7.2).
  2. Dissolution(API + Finished Product)
  3. Composition & Process similarity
Permeability:
  1. We are going to file Literature support for Pregabalin high Permeable (Class I) whether USFDA will accept our ANDA or not?
Regards,
A.Anand
Bio-PK

Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,658 registered users;
78 visitors (0 registered, 78 guests [including 6 identified bots]).
Forum time: 06:49 CEST (Europe/Vienna)

So far as I can remember,
there is not one word in the Gospels
in praise of intelligence.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5